Profermin®: Prevention of Progression in Alcoholic Liver Disease by Modulating Dysbiotic Microbiota
Clinical trial NCT03863730 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03863730
- Sponsor
- Odense University Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-01
- Primary completion
- 2021-07-15
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.